Molecular Partners
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and immunology. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.
Link from a Wikipage to another Wikipage
primaryTopic
Molecular Partners
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and immunology. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.
has abstract
Molecular Partners AG is a cli ...... es in preclinical development.
@en
assets ($)
founding year
industry
key person
location city
number of employees
type
Link from a Wikipage to an external page
Wikipage page ID
48,536,390
page length (characters) of wiki page
Wikipage revision ID
1,022,651,503
Link from a Wikipage to another Wikipage
assets
founded
hq location city
Schlieren, Zürich, Switzerland
@en
industry
key people
Andreas Emmenegger, Chief Financial Officer
@en
Dr. Michael Stumpp, Chief Operating Officer
@en
Dr. Nicolas Leupin, Chief Medical Officer
@en
Dr. Patrick Amstutz, Chief Executive Officer
@en
William M. Burns, Chairman of the Board
@en
logo
@en
name
Molecular Partners AG
@en
num employees
type
wikiPageUsesTemplate
subject
hypernym
comment
Molecular Partners AG is a cli ...... es in preclinical development.
@en
label
Molecular Partners
@en
sameAs
wasDerivedFrom
isPrimaryTopicOf
name
Molecular Partners AG
@en